News and social media are saturated with articles about the demand for and shortage of glucagon-like peptide-1 (GLP-1) drugs marketed for weight loss. The best-known of these drugs is semaglutide, sold under the brand…
Continue Reading
What You Should Know: – Prescriptions for the popular weight loss drug Wegovy showed a six-fold increase between December 2022 and June 2023, according to a recent analysis of prescribing trends by DrFirst. –…
Continue Reading
George Kramb, CEO and co-founder of PatientPartner
You’ve probably heard about Ozempic, especially if you’re one of the millions who regularly scroll through TikTok or browse other social media platforms. It’s the drug that influencers…
Continue Reading
GLP-1s — which lower blood sugar to help people lose weight — are taking the healthcare industry by storm and have several implications for digital health companies. This includes headwinds for established nutrition programs…
Continue Reading
News
Nuance announces GA of Dragon Ambient EXperience (DAX) Copilot, formerly known as DAX Express, that uses conversational, ambient, and generative AI to help physicians create medical documentation.
OpenAI updates ChatGPT to support using browser-based…
Continue Reading
Hospitals’ pharmacy spending is projected to rise by 3.42% next year, according to a new report published by Vizient. Specialty drugs and neurology medications are the primary drivers of this increase in pharmacy expenses.
Vizient…
What You Should Know:
With 42 percent of Americans now struggling with obesity, doctors and their patients are looking for a sustainable approach to weight loss. Currently, prescription medications known as the GLP-1 class of anti-obesity…
Continue Reading
Virtual primary care company LifeMD is jumping on the glucagon-like peptide 1 (GLP-1) train through its launch of a weight management program, the company announced Tuesday.
New York City-based LifeMD is a direct-to-consumer company and…
